Highly selective 5-HT(2C) receptor agonists having antagonist activity at the 5-HT(2B) receptor

Details for Australian Patent Application No. 2011212930 (hide)

Owner The Board of Trustees of the University of Illinois The University Of North Carolina At Chapel Hill

Inventors Kozikowski, Alan; Roth, Bryan; Svennebring, Andreas; Chen, Gang; Cho, Sung Jin

Agent Watermark

Pub. Number AU-A-2011212930

PCT Pub. Number WO2011/097336

Priority 61/301,441 04.02.10 US

Filing date 3 February 2011

Wipo publication date 11 August 2011

International Classifications

C07C 217/14 Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton

A61K 31/138 - Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine

A61P 3/00 Drugs for disorders of the metabolism

A61P 25/00 Drugs for disorders of the nervous system

C07C 217/74 Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton

Event Publications

6 September 2012 PCT application entered the National Phase

  PCT publication WO2011/097336 Priority application(s): WO2011/097336

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011212938-Compounds and methods for enhancing salty taste

2011212929-Compositions of prokaryotic phenylalanine ammonia-lyase variants and methods of using compositions thereof